Question Bank › Better business coming in than going out

Better business coming in than going out

Better business coming in than going out: management describes the quality of new intake visibly exceeding what it is re

Calls Tested
483
Answered YES
22
Hit Rate
4.6%
rare by design

Globe Life Inc. (GL) — this company's answers

NO on the Q1 2024 call 2024-04-23 F
The model's full reasoning — Q1 2024 call → NOWe need to determine if management conveys that the business being taken in now is of visibly higher quality than the business it is replacing, with both halves: (1) an in-versus-out quality contrast stated by management, and (2) the turnover is real, current, and already in the numbers' future. Let's examine the transcript. Management discusses various segments. They talk about sales, agent counts, premium growth, etc. They mention that they are investing in technology, and that at Liberty National they implemented a new underwriting platform which temporarily slowed policy issues, but they expect throughput to return to normal. They also discuss Direct to Consumer sales declining due to reduced marketing spend on campaigns that did not meet profit objectives. They say they will continue to focus on maximizing underwriting margin dollars on new sales by managing rising advertising and distribution costs. Is there any explicit contrast between the quality of new business being taken in versus the old business? They mention that they are reducing marketing spend on certain campaigns that did not meet profit objectives, which implies they are being more selective, but they don't explicitly say that the new business is of higher quality than the existing book. They talk about managing costs, but not about better margins on new business. They also discuss American Income Life, where they have strong agent count growth and sales growth. They mention that over 80% of premiums come from policies in force over one year, but that's about the stability of the book, not about new business being better. They discuss investment yields: they invested in fixed maturities at 5.86% yield, and they expect to invest at 5.6-5.8% for the year. They also invest in commercial mortgage loans and LPs at higher expected returns. But that's about investment portfolio, not about the insurance business itself. The question is about the business the company is taking in right now (i.e., new policies, new sales) being of higher quality than the business it is replacing (i.e., older policies that are running off). Management does not seem to make such a contrast. They talk about sales growth, agent counts, but not about the economics of new business versus old business.

← Back to the full GL analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management convey that the business the company is TAKING IN RIGHT NOW is of visibly HIGHER QUALITY than the business it is finishing, replacing, or letting run off — that is, does management contrast the character of its NEW incoming work, orders, contracts, customers, products, or engagements against the OLDER business still sitting in its reported results, and indicate that as the old naturally rolls off and the new becomes a bigger share, the company's results will improve on the strength of business ALREADY being taken in today? Answer YES when management's own words convey, in whatever form fits the industry, ONE coherent phenomenon with both halves present as a present-tense reality: (1) AN IN-VERSUS-OUT QUALITY CONTRAST, STATED BY MANAGEMENT. Management describes the business currently entering the company as better than what it is replacing — better priced, better margined, better terms, longer duration, more valuable work, stronger or higher-quality customers, a richer product or service mix, or otherwise economically superior — and makes the comparison against the company's OWN existing or outgoing book, not against competitors or the market. The forms vary widely: new orders or bookings coming in at better economics than the work being completed; new contracts, policies, leases, loans, or engagements written on better terms than those expiring; the sales mix of what is being sold now visibly richer than the mix still dominating reported results; lower-quality, lower-margin, or problematic business being deliberately allowed to run off while better business fills its place; or management explaining that what is in the backlog, book, or pipeline of committed work today carries better economics than what is currently being recognized. (2) THE TURNOVER IS REAL, CURRENT, AND ALREADY IN THE NUMBERS' FUTURE. The higher-quality intake must be described as actually being received, signed, booked, or written NOW — real transactions already happening, not aspirations to move upmarket or plans to improve mix — and management should convey, directly or plainly in substance, that reported results still largely reflect the older, lower-quality business, so the improvement arrives as the mix naturally turns over, without depending on new demand, market recovery, or events not yet secured. Answer NO if management discusses only overall demand strength, volume growth, or a good quarter without contrasting the quality of incoming business against outgoing. NO if the improvement in economics comes chiefly from raising prices to pass through costs, or from market prices moving favorably, rather than from a genuine change in the character of the business being taken in. NO if the better mix is only targeted, planned, or hoped for rather than already arriving. NO if the contrast is purely between a good quarter and a bad quarter, or between this company and competitors, rather than between the company's own incoming and outgoing business. NO if the new business's superiority is asserted only generically ("higher quality growth", "improving mix") with nothing concrete about what makes the incoming business better. NO if the reported results already fully reflect the better mix, with no meaningful turnover still ahead. NO if the idea appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASB Associated Banc-Corp Q1 2024 2024-04-25 A
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
ALL The Allstate Corporation Q3 2023 2023-11-02 C+
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
OEC Orion Engineered Carbons S.A. Q4 2022 2023-02-17 B+
BBD Banco Bradesco S.A. Q3 2022 2022-11-09 D
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
KTB Kontoor Brands, Inc. Q3 2021 2021-11-04 A
CYBR CyberArk Software Ltd. Q3 2021 2021-11-04 B+
EHTH eHealth, Inc. Q2 2021 2021-07-29 F
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
GECC Great Elm Capital Corporation Q3 2018 2018-11-13 B
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
T AT&T Inc. Q3 2018 2018-10-24 C+
ESS Essex Property Trust, Inc. Q2 2018 2018-08-03 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
ALLY Ally Financial Inc. Q1 2018 2018-04-26 B+
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
HSTM HealthStream, Inc. Q3 2017 2017-10-24 C
MTG MGIC Investment Corporation Q3 2017 2017-10-18 B+
BLKB Blackbaud, Inc. Q1 2017 2017-05-02 B+

How the model reasoned

HSTM · Q3 2017 → YESThe question is about whether management conveys that the business they're taking in right now is of visibly higher quality than the business they're finishing or letting run off. YES The transcript shows management explicitly contrasting incoming business against outgoing: - Patient Experience: "Existing clients also continue to convert from a phone modality to email and SMS text surveying modality... This conversion trend to continue... expected to have a positive impact... on patient experience margins." (lower price, higher margin shift already happening) - Provider Solutions: "the move from installed software sales to software as service sales... challenge revenue growth... but not profitability growth" and "backlog of unimplemented customers... significantly reduced" - Laerdal/HeartCode: "the new product we believe is right now based on contracts.
GFS · Q3 2021 → YESThe question is about whether management conveys that the business they're taking in right now is of visibly higher quality than the business they're finishing or letting run off. YES The transcript shows management explicitly contrasting the incoming business with the outgoing: compute revenue is declining "as expected" due to customers shifting to smaller nodes, while "newer high-margin customer designs" are ramping in 2H 2022 to offset it. They tie this directly to mix improvement from "d differentiated solutions become a larger portion" and "feature-rich" platforms (FDX, RF SOI, silicon photonics) growing while feature-rich CMOS is flat or down. LTAs signed now carry "pricing improvements" baked in for 2022+, with new agreements committing future capacity at those better terms.
CYBR · Q3 2021 → YESThe question is about whether management conveys that the new business they're taking in is of higher quality than the old business they're replacing, and that as the old rolls off, results will impro...YES Management explicitly contrasts the incoming subscription business (new logos, SaaS bookings, Privileged Cloud, EPM) as higher-quality than the outgoing perpetual license business it is replacing. They describe it as delivering “faster type of value,” “higher lifetime value over time,” and “more users and more products faster ,” while noting that the current revenue and profitability headwind from the mix shift is “obscuring the P&L” and that results will improve once the transition completes.

More from the question bank

Doing more and earning better on each oneFrom explaining to teachingBought-and-paid-for optionalityExit rate above the printCheck it yourselvesCompounding order flowAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.